accuray.com (ARAY) - Revenue and Sales Volume

Symbol and logo of brand Accuray (ARAY)

By attracting elite engineers through prestige and social guarantees, Accuray Incorporated (ARAY) ensures business stability. The company's sales volume clearly demonstrates this trend, where the 0.39 level reflects the current value of the indicator. The integration of software with hardware creates a sustainable dependence of clinics on the service, while the flawless image of the CyberKnife creator guarantees the full trust of the global medical community.

Revenue and Sales Volume: Accuray Incorporated (ARAY) for 07/04/2022 - 11/14/2026

Analytical breakdowns for Accuray Incorporated

- market price and analyst price targets:
- market capitalization indicators:
Summary company analysis:ARAY, Accuray, Inc.
Core merchandise of Accuray Inc

The implementation of radiation therapy systems in California provides Accuray Incorporated (ARAY) with a steady revenue stream. This indicator captures the daily volume of actual cash inflows, reflecting the real-time execution speed of operational plans. Investors utilize this metric to assess current demand for complex medical systems. Sharp fluctuations in these values may signal an asset revaluation. By analyzing the company's sales chronology, one can determine the fundamental stability of the business.

Competing companies

Company Total Revenue BeiGene Oncology ONC|Revenue and Sales Volume HALO|Revenue and Sales Volume revmed.com (RVMD)|Revenue and Sales Volume AAPG (Ascentage Pharma)|CGON - Company Sales|UroGen - Revenue and Sales Volume|Bicara Corp (BCAX) - Company Sales|PSNL (Personalis, Inc.) - Company Sales|erasca.com (ERAS) - Revenue and Sales Volume|Company Revenue Delcath Systems|YMAB: Company Sales Revenue|Revenue and Sales Volume AURA|Revenue and Sales Volume candeltx.com (CADL)|SELLAS Life Sciences Group - Company Sales|actuatetherapeutics.com (ACTU) - Company Total Revenue|CTOR: Company Sales|Company Sales Revenue HURA (TuHURA Biosciences, Inc.)|TARA: Revenue and Sales Volume|FATE - Company Gross Revenue|Company Revenue Aadi Bioscience, Inc.|Company Sales Volume TCRX (TScan)|Revenue and Sales Volume CSBR|Company Sales xbiotech.com XBIT|Company Revenue CEL-SCI CVM|OS Therapies, Inc. (OSTX) - Company Total Revenue|RADX - Company Revenue|Company Sales Revenue ARTV (Artiva Biotherapeutics, Inc.)|adlainortye.com (ANL) - Company Revenue|Company Annual Revenue VERU (Veru Inc)|Company Revenue Tempest Tx|Company Total Revenue Xilio XLO|Company Revenue Renovaro Inc. (RENB)|MURA (muraloncology.com) - Company Sales Revenue|Revenue and Sales Volume KAPA (Kairos Pharma)|Revenue and Sales Volume OnKure Therapeutics, Inc. OKUR|GDTC: Company Sales|Curis, Inc. - Company Total Sales|APLM: Revenue and Sales Volume|Company Total Revenue tharimmune.com (THAR)|ADVB (Advanced Biomed Inc.) - Revenue and Sales Volume|Company Sales Volume GNPX (Genprex Inc.)|Revenue and Sales Volume CLDI|Revenue and Sales Volume Sunshine Biopharma Inc. (SBFM)|Company Revenue Xenetic Biosciences, Inc. XBIO|Company Sales Revenue SLRX|Purple Biotech Ltd. - Revenue and Sales Volume|AONC - Revenue and Sales Volume|BGNE (BeOne Medicines) - Company Sales|Company Total Revenue Checkpoint Therapeutics Inc (CKPT)|ELEV (Elevation Oncology, Inc.) - Revenue and Sales Volume|Company Sales iCAD Corp (ICAD)|Revenue and Sales Volume IKNA|Revenue and Sales Volume Notable Labs Ltd (NTBL)|Company Revenue Viracta Therapeutics, Inc. VIRX|MOR: Company Sales Volume|NAYA Biosciences - Revenue and Sales Volume|ascentage.com (AAPGV) - Company Sales